Acetylsalicylic acid (ASA) or aspirin is a pro-drug of salicylates which has significant effect in reducing the cardiovascular events. Potential polymorphic enzymes responsible for the pharmacokinetic variations of ASA include cyclooxygenase-l (COX-1) UDP—glucuronosyltransferase (UGT1A6) and P450 (CYP) (CYP2C9). The main objective of this study is to determine the types and frequencies of variants of genes encoding COX-1 (A-842G), UGT1A6 (UGT1A6*2; A541G and UGT1A6*3; A522C and CYP2C9 (CYP2C9*3; A1075C) in the three major ethnic groups in Malaysian population (Malays, Chinese and Indian). The relevance of those polymorphisms in patients with cardiovascular disease was investigated. The project was approved by relevant Research Ethics Commit...
There are significant ethnic differences in the metabolism of some drugs that can be explained by cy...
Objective: Evidence is mounting suggesting that a strong genetic component underlies aspirin insensi...
The cardiovascular safety of cyclooxygenase-2 (COX-2) selective non-steroidal anti-infla...
11 páginasPolymorphisms in drug-related enzymes and receptors are often strongly related to altered ...
1<p>Nucleotide change or alternative name as most often termed in the existing literature. <sup>2</s...
Aspirin prevents thrombotic events by inhibiting platelet cyclooxygenase-1 (COX-1), thus reducing th...
PhD ThesisChronic diseases such as cardiovascular diseases and colorectal cancer are the leading ca...
AbstractBackgroundDual antiplatelet therapy is the cornerstone in the management of acute coronary s...
Introduction: Antithrombotic agents are the basic therapeutic option for patients with arterial thro...
In developed countries cardiovascular disease is one of the leading causes of death. Cardiovascular ...
<div><p>Objective</p><p>Evidence is mounting suggesting that a strong genetic component underlies as...
Cyclooxygenase-derived prostaglandins modulate cardiovascular disease risk. We genotyped 2212 Athero...
Aspirin, or Acetylsalicylic acid (ASA), is renowned for its pain-relieving and anti-inflammatory pro...
Despite the wide benefits of aspirin and its cost-effectiveness, aspirin prescriptions have been red...
Regular aspirin use is associated with reduced risk of colorectal cancer (CRC). Variation in aspirin...
There are significant ethnic differences in the metabolism of some drugs that can be explained by cy...
Objective: Evidence is mounting suggesting that a strong genetic component underlies aspirin insensi...
The cardiovascular safety of cyclooxygenase-2 (COX-2) selective non-steroidal anti-infla...
11 páginasPolymorphisms in drug-related enzymes and receptors are often strongly related to altered ...
1<p>Nucleotide change or alternative name as most often termed in the existing literature. <sup>2</s...
Aspirin prevents thrombotic events by inhibiting platelet cyclooxygenase-1 (COX-1), thus reducing th...
PhD ThesisChronic diseases such as cardiovascular diseases and colorectal cancer are the leading ca...
AbstractBackgroundDual antiplatelet therapy is the cornerstone in the management of acute coronary s...
Introduction: Antithrombotic agents are the basic therapeutic option for patients with arterial thro...
In developed countries cardiovascular disease is one of the leading causes of death. Cardiovascular ...
<div><p>Objective</p><p>Evidence is mounting suggesting that a strong genetic component underlies as...
Cyclooxygenase-derived prostaglandins modulate cardiovascular disease risk. We genotyped 2212 Athero...
Aspirin, or Acetylsalicylic acid (ASA), is renowned for its pain-relieving and anti-inflammatory pro...
Despite the wide benefits of aspirin and its cost-effectiveness, aspirin prescriptions have been red...
Regular aspirin use is associated with reduced risk of colorectal cancer (CRC). Variation in aspirin...
There are significant ethnic differences in the metabolism of some drugs that can be explained by cy...
Objective: Evidence is mounting suggesting that a strong genetic component underlies aspirin insensi...
The cardiovascular safety of cyclooxygenase-2 (COX-2) selective non-steroidal anti-infla...